Eric Roos is an executive biotechnology leader with a unique, 30-year track record that bridges deep
technical innovation with high-value corporate strategy, business development, and strategic partnerships.
He possesses a rare blend of expertise, having personally pioneered, patented, and scaled advanced
therapeutic platforms before transitioning into the executive suite to lead multi-billion-dollar global alliances.
Throughout his career in high-growth and global life sciences companies, Eric has consistently created
enterprise value by aligning R&D execution with commercial readiness. His core strengths sit at the
intersection of technical depth and strategic leadership, establishing robust infrastructure for advanced
therapeutic modalities, cell and gene therapies, and regenerative medicine globally.